- Home
- USEG vs RLYB Comparison
USEG vs RLYB Comparison
Compare USEG & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USEG | RLYB |
|---|---|---|
| Founded | 1966 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.3M | 28.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | USEG | RLYB |
|---|---|---|
| Price | $0.99 | $0.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 159.3K |
| Earning Date | 03-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,484,000.00 | $674,000.00 |
| Revenue This Year | N/A | $17.61 |
| Revenue Next Year | $57.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.71 |
| 52 Week Low | $0.91 | $0.22 |
| 52 Week High | $6.40 | $0.95 |
Technical Indicators
Market Signals| Indicator | USEG | RLYB |
|---|---|---|
| Relative Strength Index (RSI) | 49.06 | 44.33 |
| Support Level | $0.98 | $0.58 |
| Resistance Level | $1.11 | $0.74 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 43.09 | 46.23 |
Price Performance
Historical ComparisonAbout USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.